Skip to content
In English |
En español
National Cancer Institute
at the National Institutes of Health
Search
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Clinical Trials Search Results
Page Options
Email This Document
Clinical Trial Questions?
Get Help:
1-800-4-CANCER
LiveHelp online chat
Popular Resources
Help Using the NCI Clinical Trials Search Form
How to Find a Cancer Treatment Trial
Learn About Clinical Trials
About NCI's List of Cancer Clinical Trials
NCI Dictionary of Cancer Terms
NCI Drug Dictionary
Featured Clinical Trials Supported by NCI
View Content for:
Patients
Health Professionals
Display:
Title
Description with:
Locations
Eligibility
Full Trial Description
Custom
Results 1-4 of 4 for your search:
Drug:
trifluoperazine hydrochloride
Find trials that include:
Any drugs shown
Trial Status:
Closed
Hide Search Criteria
Show Search Criteria
Help with Results
Select All on Page
Sort by:
Phase of Trial
Title
Type of Trial
Status of Trial
Age Range
Sponsor of Trial
Protocol IDs
Show
10
25
50
100
200
Results per Page
1.
Phase II Evaluation of Trifluoperazine to Overcome Doxorubicin Resistance in Patients with Breast Cancer
Phase:
Phase II
Type:
Treatment
Status:
Closed
Age:
18 to 70
Sponsor:
NCI
Protocol IDs:
YALE-HIC-3909
, NCI-T86-0181D, T86-0181
2.
Phase II Chemotherapy with BLEO plus Chemopotentiation with Trifluoperazine in Patients with Malignant Brain Tumors
Phase:
Phase II
Type:
Treatment
Status:
Completed
Age:
18 to 70
Sponsor:
Protocol IDs:
YALE-HIC-3839
, NCI-V86-0093
3.
Phase I/II Pilot Study of Trifluoperazine and Continuous Infusion Vinblastine in Women with Advanced Breast Cancer Refractory to Initial Treatment (Summary Last Modified 05/92)
Phase:
Phase II
Type:
Treatment
Status:
Closed
Age:
18 and over
Sponsor:
Protocol IDs:
YALE-HIC-4951
, NCI-V89-0226
4.
Phase II Study of DOX/VBL Combined with P-Glycoprotein Inhibitors (Trifluoperazine and Verapamil) in Patients with Advanced Renal Cell Carcinoma (Summary Last Modified 04/93)
Phase:
Phase II
Type:
Treatment
Status:
Closed
Age:
adult
Sponsor:
NCI
Protocol IDs:
SWOG-9104
Select All on Page
Help with Results
We Can Answer Your Questions
1-800-4-CANCER
LiveHelp Online Chat
NCI Home
Contact Us
Policies
Accessibility
Viewing Files
FOIA
Site Help
Site Map
Follow Us:
Twitter
YouTube
Facebook
RSS
Other Versions:
Mobile
|
Español
U.S. Department of Health and Human Services
National Institutes of Health
National Cancer Institute
USA.gov
NIH…Turning Discovery Into Health
®